{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:23Z","timestamp":1792091363644,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Deanship of Scientific Research at King Saud University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.05.062","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T13:30:40Z","timestamp":1495200640000},"page":"58-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats"],"prefix":"10.1016","volume":"92","author":[{"given":"Hatem M.","family":"Abuohashish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Al-Rejaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin-angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248413501018","article-title":"Renin-angiotensin system blocking drugs","volume":"19","author":"Robles","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2017.05.062_bib0015","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.biopha.2017.05.062_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2017.05.062_bib0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0092-8674(86)90785-3","article-title":"Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains","volume":"45","author":"Young","year":"1986","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(94)91171-1","article-title":"Evidence that angiotensin-(1\u20137) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors","volume":"665","author":"Fontes","year":"1994","journal-title":"Brain Res."},{"issue":"14","key":"10.1016\/j.biopha.2017.05.062_bib0035","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2017.05.062_bib0040","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2017.05.062_bib0045","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3892\/mmr.2014.1978","article-title":"Role of the local bone reninangiotensin system in steroidinduced osteonecrosis in rabbits","volume":"9","author":"Zhang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2017.05.062_bib0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1271\/bbb.120123","article-title":"Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice","volume":"76","author":"Gu","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2017.05.062_bib0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1440-1797.2012.01656.x","article-title":"Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice","volume":"17","author":"Gu","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","article-title":"Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes","volume":"32","author":"Diao","year":"2014","journal-title":"J. Bone Miner. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2017.05.062_bib0065","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","article-title":"Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation \u2212 role of a local renin-angiotensin system","volume":"159","author":"Garcia","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2017.05.062_bib0070","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","article-title":"Angiotensin II accelerates osteoporosis by activating osteoclasts","volume":"22","author":"Shimizu","year":"2008","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","article-title":"Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts","volume":"29","author":"Liu","year":"2011","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","article-title":"Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis","volume":"47","author":"Yongtao","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1520005","article-title":"Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro","volume":"152","author":"Hatton","year":"1997","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00467-003-1361-4","article-title":"Angiotensin II reduces calcium uptake into bone","volume":"19","author":"Schurman","year":"2004","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/bbrc.1996.5914","article-title":"Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae","volume":"230","author":"Hiruma","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pros.22542","article-title":"Angiotensin-(1\u20137) attenuates metastatic prostate cancer and reduces osteoclastogenesis","volume":"73","author":"Krishnan","year":"2013","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2008.10.022","article-title":"Angiotensin-(1\u20137) enhances angiotensin II induced phosphorylation of ERK1\/2 in mouse bone marrow-derived dendritic cells","volume":"46","author":"Nie","year":"2009","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2017.05.062_bib0110","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of beta-blockers and risk of fractures","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biopha.2017.05.062_bib0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","article-title":"Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms","volume":"16","author":"Perez-Castrillon","year":"2003","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.biopha.2017.05.062_bib0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone"},{"issue":"18","key":"10.1016\/j.biopha.2017.05.062_bib0125","first-page":"692","article-title":"[Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril]","volume":"127","author":"Garcia-Testal","year":"2006","journal-title":"Med. Clin. (Barc)."},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","article-title":"Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis","volume":"46","author":"Ghosh","year":"2014","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.biopha.2017.05.062_bib0140","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3346\/jkms.2013.28.8.1139","article-title":"The effects of antihypertensive drugs on bone mineral density in ovariectomized mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1540467","article-title":"Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats","volume":"154","author":"Ma","year":"1997","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2017.05.062_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/gpb_2016015","article-title":"A comparative study between the effect of 17-beta estradiol and angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats","volume":"35","author":"Alaam","year":"2016","journal-title":"Gen. Physiol. Biophys."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2017.05.062_bib0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.drudis.2010.02.003","article-title":"Angiotensin-converting enzymes and drug discovery in cardiovascular diseases","volume":"15","author":"Shi","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2017.05.062_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejphar.2008.02.090","article-title":"Angiotensin-(1\u20137): pharmacological properties and pharmacotherapeutic perspectives","volume":"585","author":"Iusuf","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0165","article-title":"Angiotensin II and angiotensin-(1\u20137) restore salt-Induced vascular dysfunction via distinct mechanisms","volume":"25","author":"Raffai","year":"2011","journal-title":"The FASEB Journal"},{"issue":"1-3","key":"10.1016\/j.biopha.2017.05.062_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2012.04.001","article-title":"The Mas receptor mediates modulation of insulin signaling by angiotensin-(1\u20137)","volume":"177","author":"Munoz","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biopha.2017.05.062_bib0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2014.07.015","article-title":"Beneficial effects of houttuynin on ventricular remodeling induced by coronary artery ligation in rats","volume":"740","author":"Gao","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2017.05.062_bib0180","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3945\/jn.108.101071","article-title":"Diet calcium level but not calcium supplement particle size affects bone density and mechanical properties in ovariectomized rats","volume":"139","author":"Shahnazari","year":"2009","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/aps.2014.111","article-title":"The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model","volume":"36","author":"Abuohashish","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2017.05.062_bib0190","doi-asserted-by":"crossref","first-page":"316134","DOI":"10.1155\/2014\/316134","article-title":"Association between postmenopausal osteoporosis and experimental periodontitis","volume":"2014","author":"Luo","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"Suppl. 4","key":"10.1016\/j.biopha.2017.05.062_bib0195","doi-asserted-by":"crossref","first-page":"125S","DOI":"10.1016\/8756-3282(95)00285-L","article-title":"FDA Guidelines and animal models for osteoporosis","volume":"17","author":"Thompson","year":"1995","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.biopha.2017.05.062_bib0200","first-page":"424","article-title":"The laboratory rat as an animal model for osteoporosis research","volume":"58","author":"Lelovas","year":"2008","journal-title":"Comp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.05.062_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.toxlet.2008.11.006","article-title":"Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats","volume":"184","author":"Hertrampf","year":"2009","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4162\/nrp.2009.3.2.108","article-title":"Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet","volume":"3","author":"Choi","year":"2009","journal-title":"Nutr Res Pract"},{"issue":"4","key":"10.1016\/j.biopha.2017.05.062_bib0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.phymed.2008.12.006","article-title":"Antiosteoporotic activity of icariin in ovariectomized rats","volume":"16","author":"Nian","year":"2009","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0220","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.106.102798","article-title":"An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-c yclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats","volume":"318","author":"Kim","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2017.05.062_bib0225","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1210\/endo.142.11.8504","article-title":"Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice","volume":"142","author":"Geary","year":"2001","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.biopha.2017.05.062_bib0230","doi-asserted-by":"crossref","first-page":"E817","DOI":"10.1152\/ajpendo.00733.2007","article-title":"Cross-talk between estrogen and leptin signaling in the hypothalamus","volume":"294","author":"Gao","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.peptides.2012.06.005","article-title":"Captopril intake decreases body weight gain via angiotensin-(1\u20137)","volume":"37","author":"Oh","year":"2012","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.biopha.2017.05.062_bib0240","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10735-012-9427-x","article-title":"Tissue specific localization of angiotensin-(1\u20137) and its receptor Mas in the uterus of ovariectomized rats","volume":"43","author":"Vaz-Silva","year":"2012","journal-title":"J. Mol. Histol."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/13102818.2007.10817444","article-title":"Causes of high bone alkaline phosphatase","volume":"21","author":"Sara","year":"2007","journal-title":"Biotechnol. Biotechnol. Equip."},{"issue":"4","key":"10.1016\/j.biopha.2017.05.062_bib0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.17221\/1921-VETMED","article-title":"Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in early stages of canine osteoarthritis","volume":"53","author":"Lee","year":"2008","journal-title":"Vet. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","article-title":"Rapid bone loss is associated with increased levels of biochemical markers","volume":"13","author":"Ross","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"31","key":"10.1016\/j.biopha.2017.05.062_bib0260","doi-asserted-by":"crossref","first-page":"28370","DOI":"10.1074\/jbc.M502469200","article-title":"Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts","volume":"280","author":"Ljusberg","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12291-010-0074-2","article-title":"BMD and serum intact osteocalcin in postmenopausal osteoporosis women","volume":"26","author":"Jagtap","year":"2011","journal-title":"Indian J. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10408360801949442","article-title":"Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis","volume":"45","author":"Vasikaran","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0275","first-page":"55","article-title":"Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients","volume":"33","author":"Hou","year":"2003","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jjco\/27.1.26","article-title":"Sequential changes of urinary pyridinoline and deoxypyridinoline as markers of metastatic bone tumor in patients with prostate cancer: a preliminary study","volume":"27","author":"Samma","year":"1997","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0285","first-page":"145","article-title":"Investigation of serum crosslinked N-telopeptides of type I collagen (NTx) levels and total antioxidant capacity in patients with type 2 diabetes mellitus","volume":"35","author":"Kurban","year":"2010","journal-title":"Turk. J. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2017.05.062_bib0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1469-7580.2010.01242.x","article-title":"Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis","volume":"217","author":"Ferretti","year":"2010","journal-title":"J. Anat."},{"issue":"6","key":"10.1016\/j.biopha.2017.05.062_bib0295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1138\/20110516","article-title":"Bone mineralization and regulation of phosphate homeostasis","volume":"8","author":"Sapir-Koren","year":"2011","journal-title":"IBMS BoneKEy"},{"issue":"2","key":"10.1016\/j.biopha.2017.05.062_bib0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MNH.0b013e328031f362","article-title":"Angiotensin-(1\u20137) and the renin-angiotensin system","volume":"6","author":"Santos","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2017.05.062_bib0305","first-page":"533","article-title":"Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women","volume":"10","author":"Prasad","year":"2014","journal-title":"Vasc. Health Risk Manag."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217311873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217311873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:44:25Z","timestamp":1772264665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217311873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":61,"alternative-id":["S0753332217311873"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.062","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}